Peptide Therapy After 40: Evidence, Safety and Telemedicine

APP education • Founder and developer: Richard W. Hare, DC, NASM-CES, NASM-PES, CSCS • Expanded and sources checked September 30, 2026. See editorial standards and evidence. This page does not carry an independent medical-review endorsement.

Explore peptide therapy with clear information about evidence, regulatory status, and clinician evaluation. APP provides education and a referral pathway for peptide-related questions through the independent DreamBody RX telemedicine partner.

Evaluate each peptide and each proposed use separately

Peptide is a broad category, not a guarantee of effectiveness. An approved medicine for one condition does not establish that other peptides improve recovery, body recomposition, or longevity. Laboratory mechanisms and early studies cannot establish a reliable anti-aging benefit.

Questions for an independent licensed clinician

Ask about the exact substance, intended indication, evidence in people, approval status, legal availability, risks, alternatives, and follow-up. FDA has identified potential significant safety risks for substances including CJC-1295 and ipamorelin used in compounding. A consultation does not guarantee a prescription or availability.

How to judge a peptide-therapy claim

Begin with the exact compound and the proposed use. Two products described as peptides can have very different evidence, manufacturing requirements, and clinical risks. Ask whether the evidence concerns the same substance, dose, route, population, and outcome being advertised.

Questions that clarify the evidence
Claim or labelWhat to ask
“Clinically studied”Was the study in humans, and did it measure a meaningful outcome?
“FDA-approved”Which exact product and indication are approved?
“Compounded”Why is compounding being considered, and what are the applicable requirements?
“Research use only”This is not a clinical prescribing pathway or assurance of suitability for human use.
“Anti-aging”What outcome improved, compared with what, and for how long?

Approved use, off-label use, and compounded products

These terms should not be used interchangeably. An approved drug has an approved product and indication. Off-label use concerns a clinician’s use of an approved medicine beyond its approved labeling. A compounded product is not FDA-approved, and it is not reviewed by FDA for safety, effectiveness, and quality before marketing in the same way as an approved drug. Current legal and clinical availability must be checked by the treating provider and pharmacy.

Prepare for a peptide-related evaluation

  1. Write down the goal you want to discuss, such as a diagnosed condition or a concern about body composition.
  2. Bring your medication and supplement list to the provider’s clinical intake.
  3. Ask what established alternatives exist and what happens if no treatment is appropriate.
  4. Ask how adverse effects, response, and discontinuation would be monitored.
  5. Confirm the full evaluation, testing, treatment, and follow-up costs directly with the provider.

Peptide-therapy questions

Does APP sell or prescribe injectable peptides?

APP provides education and referral navigation. The independent licensed provider determines whether any clinical treatment is appropriate and available.

Is an increase in growth hormone proof of better health or longevity?

No. A laboratory change is not the same as a demonstrated improvement in function, body composition, safety, or lifespan. Evaluate the actual outcomes and limitations of the study.

Can an article tell me which peptide I should take?

No. General education cannot determine your clinical eligibility or replace a provider’s evaluation. APP does not provide a self-injection protocol on this page.

Where can I explore the independent pathway?

Visit the DreamBody RX peptide-related evaluation section. APP may receive compensation through its referral relationship. The provider decides eligibility, testing, prescribing, and follow-up.

FDA: Human drug compounding.

How APP can help

Ageless Performance Project provides educational resources and performance consulting. Start with your goal, review the information below, and choose the next step that fits your needs. Medical evaluations and treatment are provided by independent licensed clinicians, who determine eligibility and appropriate care.

Explore APP performance consulting · Free tools and blueprints · Explore independent telemedicine options

Continue learning

Related goals after 40

Evidence and further reading

FDA: Compounding substances with potential significant safety risks

Your next step

Book an APP consultation for nonmedical guidance, or visit the telemedicine services hub to review independent clinical pathways.

Educational content developed by Ageless Performance Project. Updated September 30, 2026. Individual outcomes vary. APP does not diagnose or prescribe through this website. APP may receive compensation from affiliated providers; see our affiliate disclosure.